Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_3
2
50%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(2)

Detailed Status

Completed2
Enrolling by invitation1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (33.3%)
Phase 32 (66.7%)

Trials by Status

completed250%
enrolling_by_invitation125%
active_not_recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
active_not_recruitingphase_3

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

NCT05776277
enrolling_by_invitation

Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

NCT06743620
completedphase_1

Autologous Cell Therapy for Treatment of Fecal Incontinence

NCT01600755
completedphase_3

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair

NCT01893138

Clinical Trials (4)

Showing 4 of 4 trials
NCT05776277Phase 3

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

Active Not Recruiting
NCT06743620

Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

Enrolling By Invitation
NCT01600755Phase 1

Autologous Cell Therapy for Treatment of Fecal Incontinence

Completed
NCT01893138Phase 3

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair

Completed

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4